CONFERENCE DAY ONE

7:30 am Check-In & Coffee

Synopsis

Light Breakfast Served

8:20 am Chair’s Opening Remarks

8:30 am Reach, Relevance, Impact: How to Build Enduring Measurement Infrastructures

Synopsis

  • Tracing the journey of measuring patient engagement and experience, with a focus on key trends
  • Identifying which trends are expected to persist, which have plateaued, and which are reversing to refine best practices
  • Envisioning the future of patient engagement measurement to create a strategic roadmap and ensure accurate data collection for evolving needs

Creating Standardized Metrics & Reporting Patient Engagement Across the Whole Product Lifecycle

9:00 am Empowering HCPs & Patients: Medscape’s ConnectedCare with Real-World Impact

Synopsis

Are patients and HCPs truly connected? 

Discover how new technologies and activation strategies are transforming patient-HCP interactions to get us closer

9:30 am Identifying & Quantifying Underserved Communities & Unmet Needs – A Spotlight on the Spot Her Campaign

Synopsis

  • Exploring how incorporating direct patient insights helped the Spot Her campaign connects with broader audiences and amplify its impact
  • Learning how data-driven insights from patient engagement outcomes informed the development of more targeted strategies, ensuring sustained efforts and meaningful connections with underserved communities
  • Discovering the benefits of collaborating with professional and patient organizations to highlight mutual efforts, amplify disease awareness, and enhance program visibility for greater impact

10:00 am Speed Networking Session

Synopsis

Join our speed networking session tailored for Patient Engagement professionals, like yourselves, to connect with fellow industry peers to facilitate rapid yet meaningful exchanges of insights and expertise. Elevate your networking experience during this session designed for impactful connections within the space.

10:30 am Morning Break & Networking

Synopsis

Light Breakfast Served

11:00 am Quantifying the Value of Proactive vs. Reactive Patient Input in the Drug Development Lifecycle

  • Josee Pelletier Global Early Drug Development, Patient Advocacy Senior Director, Research, BMS

Synopsis

  • Identifying critical times in drug development life cycle where advocacy and patient engagement provide valuable insights
  • Determining the optimal timing to ask proactive questions to maximize engagement effectiveness
  • Navigating organizational structures to advocate for proactive patient engagement and making a compelling case to teams focused on other metrics

11:30 am Measuring the Benefits of Incorporating Patient Insights in Early Trial Planning

Synopsis

  • Exploring methods for quantitatively measuring the advantages of engagement patients in early trial planning, including within the trial design process and identifying key endpoints
  • Ensuring comprehensive representation of your entire community
  • Identifying effective strategies to utilise patient measurements to improve trial design and therefore outcome

12:00 pm Measuring the Effectiveness of Condition-Based Matching

Synopsis

  • Exploring the challenges for patients and trial sponsors of study-at-a-time pre-screeners
  • Understanding what is driving the industry transition to condition-based matching
  • Measuring questionnaire effectiveness

12:10 pm Benchmarking Success: Key Metrics to Elevate Patient Recruitment & Engagement in Clinical Trials

  • Adrienne Gaggi Director of Innovative Patient Recruitment, AstraZeneca

Synopsis

  • Emphasizing the importance of tracking patient engagement as well as recruitment efforts
  • Examining the decision-making process for selecting the right metrics
  • Analyzing the outcomes of tailored metrics on recruitment and retention success

12:40 pm Lunch & Networking

Synopsis

Hot Lunch Served

1:40 pm Panel Discussion: Overcoming Constraints in Quantifying ROI When You Can’t Drive Demand

Synopsis

  • How can we take data and information and compliantly use it within the market space, given the tight constraints around driving demand and influencing prescribing behaviour
  • Examining where we can push the envelope on leveraging patients as the ‘North star’ in a compliant manner, what can be said in the public domain, and what are the risks
  • Understanding what patient engagement metrics can and can’t be shared with patients to increase awareness around products in a complaint manner

2:10 pm The Patient Advocacy & Centricity Tracker: Using a Tool to Track, Measure & Benchmark Your Patient Engagement & Advocacy Work.

  • Jenny Ousbey Chief Executive Officer & Founder, OVID Health

Synopsis

  • Discovering more about OVID’s PACT tool and its metrics
  • Learning how it can help you keep pace with your competitors
  • Understanding how to generate internal buy-in for your patient engagement / advocacy function

2:20 pm Finding the Right Mechanisms to Obtains Patient Feedback without Burdening Them

  • Delphine Nicolas Head Of Global Patient Affairs - Oncology & Operations, Servier

Synopsis

  • Examining practical example of collection patient satisfaction in a meaningful way without burdening them
  • Exploring new software and tools that can be utilized to collect data from patients
  • Analysing the results from implementing this new technology

3:00 pm Afternoon Break

3:30 pm Beyond ROI: The Patient Engagement Revolution That’s Transforming Healthcare

  • Maggie Patry Executive Vice President, Client Services, Snow Companies
  • Amelia Eanes Senior Vice President, Innovation & Strategy, Snow Companies

Synopsis

  • How to quantify the true impact of patient engagement using the Return on Engagement (ROE) framework that connects patient actions to business outcomes
  • Measuring what truly matters in healthcare through the lens of the patient experience
  • Practical strategies for implementing touchpoints that capture both online and offline engagement, turning patient stories into measurable, sustainable business results

3:40 pm Practical Session: Measuring & Demonstrating the Value of Patient Engagement Across the Medicines Life Cycle

Synopsis

Join us in this practical session, where we explore the key elements of the Novartis’ Patient Engagement Impact Measurement Framework and discuss the current methods for capturing the impact of patient engagement (PE) on business, Patient-Focused Drug Development (PFDD), and healthcare.

Key Takeaways:

  • Examine the next steps in identifying appropriate KPIs to capture and demonstrate the impact of PE activities on business strategy
  • Identify the critical tools, resources, and collaborations needed to apply and integrate the approach effectively
  • Address key challenges and critical success factors in tracking PE progress and ensuring sustainability

Join this session to discuss standardizing measurement of PE impact, exchange ideas on how to streamline PE activities, demonstrate the value and impact and drive forward the best practices in PE implementation

5:10 pm Closing Remarks

5:15 pm Measuring Patient Engagement Drinks Reception

Synopsis

We invite all participants to join us at the drinks receptions to continue meaningful conversations, connect with peers facing similar challenges, and share practical insights on driving truly patient-centered strategies. This is your opportunity to strengthen your network, exchange ideas, and collaborate on solutions that move the needle on engagement, outcomes, and impact.

6:15 pm End of Day One